title: The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
abstract: The cysteine protease cathepsin B is a potential drug target for reducing brain amyloid-β (Aβ) and improving memory in Alzheimer's disease (AD), as reduction of cathepsin B in transgenic mice expressing human wild-type amyloid-β protein precursor (AβPP) results in significantly decreased brain Aβ. Cathepsin B cleaves the wild-type β-secretase site sequence in AβPP to produce Aβ, and cathepsin B inhibitors administered to animal models expressing AβPP containing the wild-type β-secretase site sequence reduce brain Aβ in a manner consistent with β-secretase inhibition. But such inhibitors could act either by direct inhibition of cathepsin B β-secretase activity or by off-target inhibition of the other β-secretase, the aspartyl protease BACE1. To evaluate that issue, we orally administered a cysteine protease inhibitor, E64d, to normal guinea pigs or transgenic mice expressing human AβPP, both of which express the human wild-type β-secretase site sequence. In guinea pigs, oral E64d administration caused a dose-dependent reduction of up to 92% in brain, CSF, and plasma of Aβ40 and Aβ42, a reduction of up to 50% in the C-terminal β-secretase fragment (CTFβ), and a 91% reduction in brain cathepsin B activity, but increased brain BACE1 activity by 20%. In transgenic AD mice, oral E64d administration improved memory deficits and reduced brain Aβ40 and Aβ42, amyloid plaque, brain CTFβ, and brain cathepsin B activity, but increased brain BACE1 activity. We conclude that E64d likely reduces brain Aβ by inhibiting cathepsin B and not BACE1 β-secretase activity and that E64d therefore may have potential for treating AD patients.
authors: American Life Science Pharmaceuticals, San Diego, CA 92109, USA. ghook@alspinc.com
authors: Gregory
authors: G
authors: Hook
authors: Vivian
authors: V
authors: Hook
authors: Mark
authors: M
authors: Kindy
references: J Clin Invest. 2008 Aug;118(8):2796-807
references: 18596919
references: Nat Genet. 1992 Aug;1(5):345-7
references: 1302033
references: Biol Chem. 2008 Mar;389(3):313-20
references: 18177262
references: Neuron. 2010 Jun 10;66(5):631-45
references: 20547123
references: J Biol Chem. 2008 Mar 21;283(12):7745-53
references: 18184658
references: Biol Chem. 2001 May;382(5):735-41
references: 11517926
references: Ann Neurol. 1991 Oct;30(4):572-80
references: 1789684
references: Intern Med. 1992 Jul;31(7):841-6
references: 1450492
references: Alzheimer Dis Assoc Disord. 2003 Oct-Dec;17(4):259-66
references: 14657791
references: Biochim Biophys Acta. 1997 Mar 20;1351(1-2):17-21
references: 9116031
references: J Biol Chem. 2005 Oct 7;280(40):34186-92
references: 16103127
references: J Clin Invest. 1999 Nov;104(9):1169-70
references: 10545514
references: Curr Pharm Des. 2007;13(4):387-403
references: 17311556
references: Methods Enzymol. 2009;463:73-95
references: 19892168
references: J Neurosci Res. 2006 Sep;84(4):832-40
references: 16802320
references: Chem Pharm Bull (Tokyo). 1987 Mar;35(3):1098-104
references: 3301019
references: J Pharmacobiodyn. 1986 Aug;9(8):672-7
references: 3023601
references: Nature. 1999 Dec 2;402(6761):533-7
references: 10591213
references: Mol Cell Neurosci. 1999 Dec;14(6):419-27
references: 10656250
references: Trends Pharmacol Sci. 1994 Nov;15(11):412-9
references: 7855906
references: Biol Chem. 2005 Sep;386(9):931-40
references: 16164418
references: Neuromolecular Med. 2010 Mar;12(1):1-12
references: 20232515
references: Science. 1999 Oct 22;286(5440):735-41
references: 10531052
references: EMBO J. 2001 Sep 3;20(17):4629-33
references: 11532926
references: Neuron. 2006 Sep 21;51(6):703-14
references: 16982417
references: J Neurosci Methods. 1984 May;11(1):47-60
references: 6471907
references: Neuroscience. 1994 Apr;59(3):729-38
references: 8008216
references: Biochemistry. 1999 Aug 17;38(33):10871-7
references: 10451383
references: Biol Chem. 2007 Feb;388(2):247-52
references: 17261088
references: Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1456-60
references: 10677483
references: Nat Neurosci. 2001 Mar;4(3):231-2
references: 11224535
references: Brain Res. 1990 Aug 27;526(1):177-9
references: 1706637
references: Hum Mol Genet. 2010 Apr 15;19(R1):R12-20
references: 20413653
references: Proc Natl Acad Sci U S A. 1990 May;87(10):3861-5
references: 1692625
references: J Alzheimers Dis. 2010;22(4):1223-30
references: 20930303
references: Brain Res Bull. 1990 Apr;24(4):543-9
references: 2357585
references: Biochem Biophys Res Commun. 2009 Aug 21;386(2):284-8
references: 19501042
references: Neurosci Lett. 1993 Jan 12;149(2):137-40
references: 8474686
references: J Neurochem. 2002 Sep;82(6):1480-9
references: 12354296
references: Biochemistry. 2006 Oct 17;45(41):12393-9
references: 17029395
references: Neurobiol Dis. 2008 Aug;31(2):250-60
references: 18585048
references: Nat Med. 2008 Oct;14(10):1106-11
references: 18836460
references: Chem Biol. 2007 May;14(5):499-511
references: 17524981
references: Toxicol Appl Pharmacol. 1990 Aug;105(1):1-12
references: 2392799
references: JAMA. 2000 Mar 22-29;283(12):1571-7
references: 10735393
references: Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2628-32
references: 8464868
references: Acta Neuropathol. 2002 Sep;104(3):267-72
references: 12172912
references: Nat Med. 2003 Jul;9(7):907-13
references: 12808450
references: Semin Neurol. 2006 Nov;26(5):499-506
references: 17048151
references: Neurosci Lett. 1991 Sep 16;130(2):195-8
references: 1795881
references: Biol Chem. 2007 Sep;388(9):979-83
references: 17696783
references: Exp Neurol. 1994 Mar;126(1):119-28
references: 8157122
references: Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12683-8
references: 9770546
references: J Cell Biol. 1997 May 5;137(3):595-608
references: 9151667
references: Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):10998-1002
references: 1837142
references: Physiol Rev. 2001 Apr;81(2):741-66
references: 11274343
references: Lancet. 2006 Jul 29;368(9533):387-403
references: 16876668
references: Int J Alzheimers Dis. 2010 Sep 02;2010:
references: 20862386
references: J Biol Chem. 2002 Feb 15;277(7):4687-93
references: 11741910
references: Science. 1996 Oct 4;274(5284):99-102
references: 8810256
references: Brain Res Mol Brain Res. 1991 Jul;10(4):299-305
references: 1656157
references: J Clin Invest. 2010 Oct;120(10):3421-31
references: 20921628
references: Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11049-53
references: 10500121
references: J Mol Neurosci. 2004;22(1-2):5-11
references: 14742905
references: Neurology. 1992 Mar;42(3 Pt 1):631-9
references: 1549228
references: Neurobiol Dis. 2009 Sep;35(3):352-8
references: 19523517
references: J Alzheimers Dis. 2005 Apr;7(2):125-33; discussion 173-80
references: 15851850
references: J Biol Chem. 1999 Mar 5;274(10):6483-92
references: 10037741
references: Trends Genet. 2006 May;22(5):281-9
references: 16567017
references: Exp Neurol. 1999 Feb;155(2):187-94
references: 10072294
references: Arch Neurol. 1993 Apr;50(4):349-58
references: 8460956
references: J Biol Chem. 2001 Mar 30;276(13):10366-73
references: 11266439
references: J Pharmacol Exp Ther. 2009 Mar;328(3):813-21
references: 19064719
references: Prog Neurobiol. 2000 Jun;61(3):305-12
references: 10727777
references: Genes Brain Behav. 2002 Aug;1(3):142-55
references: 12884970
references: Biol Chem. 2010 Aug;391(8):861-72
references: 20536395
references: Biochim Biophys Acta. 2000 Mar 7;1477(1-2):98-111
references: 10708852
references: Chin J Physiol. 1994;37(4):201-12
references: 7796636
references: J Biol Chem. 2008 Oct 31;283(44):29615-9
references: 18650430
references: Lancet Neurol. 2002 Nov;1(7):409-16
references: 12849363
references: J Neurosci Methods. 1997 Jan;71(1):3-9
references: 9125370
references: Curr Pharm Des. 2010;16(25):2779-89
references: 20698821
references: Neurochem Res. 2003 Apr;28(3-4):637-44
references: 12675155